US Tech 100

18,064.80

0.02%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
USOTC
Bavarian Nordic AS (PK) (BVNRY)
Bavarian Nordic AS (PK) (BVNRY) News

BVNRY

Bavarian Nordic AS (PK) (BVNRY)

Bavarian Nordic AS (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:BVNRY

1

Date	Time	Source	Headline	Symbol	Company
07/22/2022	8:10AM	Benzinga	Benzinga Before The Bell: Snap's Dismal Earnings, Amazon's Healthcare Foray, Robinhood Moves 41B Dogecoin Into Single Wallet And Other Top Financial Stories Friday, July 22	USOTC:BVNRY	Bavarian Nordic AS (PK)
05/24/2022	8:22AM	TipRanks	Monkeypox Outbreak is Pushing Up Smallpox Vaccine Makers’ Stocks	USOTC:BVNRY	Bavarian Nordic AS (PK)
04/13/2016	11:55AM	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:BVNRY	Bavarian Nordic AS (PK)
01/12/2016	6:02AM	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	USOTC:BVNRY	Bavarian Nordic AS (PK)
01/05/2016	11:52AM	Edgar (US Regulatory)	Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)	USOTC:BVNRY	Bavarian Nordic AS (PK)
04/17/2015	10:19AM	InvestorsHub NewsWire	EDISON EQUITY RESEARCH - BAVARIAN NORDIC	USOTC:BVNRY	Bavarian Nordic AS (PK)
12/05/2014	7:00AM	InvestorsHub NewsWire	EDISON EQUITY RESEARCH - BAVARIAN NORDIC	USOTC:BVNRY	Bavarian Nordic AS (PK)
07/24/2014	1:56AM	GlobeNewswire Inc.	Bavarian Nordic Announces First Patient Treated in a Phase 1 Study of MVA-BN(r) Brachyury in Advanced Cancer	USOTC:BVNRY	Bavarian Nordic AS (PK)
05/28/2014	11:12AM	GlobeNewswire Inc.	Bavarian Nordic Announces Appointment of Paul Chaplin, Ph.D. as President & CEO	USOTC:BVNRY	Bavarian Nordic AS (PK)
05/15/2014	2:06AM	GlobeNewswire Inc.	Bavarian Nordic to Present Data Combining Its Cancer Immunotherapies With Immune Checkpoint Inhibitors at the 2014 ASCO Annua...	USOTC:BVNRY	Bavarian Nordic AS (PK)
05/14/2014	3:19AM	GlobeNewswire Inc.	Bavarian Nordic Announces First Quarter 2014 Results	USOTC:BVNRY	Bavarian Nordic AS (PK)
04/28/2014	2:54AM	GlobeNewswire Inc.	Bavarian Nordic Announces First Patient Treated in a Phase 2 Study Evaluating Its Immunotherapy Candidate CV-301 in Bladder C...	USOTC:BVNRY	Bavarian Nordic AS (PK)
03/19/2014	3:43AM	GlobeNewswire Inc.	Bavarian Nordic Announces 2013 Full Year Results	USOTC:BVNRY	Bavarian Nordic AS (PK)
10/21/2013	12:00AM	OTC Markets	Company Name Change	USOTC:BVNRY	Bavarian Nordic AS (PK)
07/13/2013	12:00AM	OTC Markets	Piggyback Qualified	USOTC:BVNRY	Bavarian Nordic AS (PK)
06/13/2013	8:37AM	OTC Markets	Venue Change	USOTC:BVNRY	Bavarian Nordic AS (PK)
05/30/2013	6:00AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:BVNRY	Bavarian Nordic AS (PK)